Motivational Interviewing to Acutely Admitted Psychiatric Patients With Comorbid Substance Use

This study has been completed.
Sponsor:
Collaborator:
St. Olavs Hospital
Information provided by:
Norwegian University of Science and Technology
ClinicalTrials.gov Identifier:
NCT00184223
First received: September 13, 2005
Last updated: July 24, 2006
Last verified: July 2006
  Purpose

The purpose for this study is to determine whether 2x45 minutes Motivational Interviewing given during hospital stay to acutely admitted psychiatric patients with substance use problems, can reduce substance use after discharge.


Condition Intervention Phase
Substance-Related Disorders
Emergency Services, Psychiatric
Behavioral: Motivational Interviewing
Phase 2

Study Type: Interventional
Study Design: Allocation: Randomized
Endpoint Classification: Safety/Efficacy Study
Intervention Model: Parallel Assignment
Masking: Single Blind
Primary Purpose: Treatment
Official Title: Motivational Interviewing to Acutely Admitted Psychiatric Patients With Comorbid Substance Use

Resource links provided by NLM:


Further study details as provided by Norwegian University of Science and Technology:

Primary Outcome Measures:
  • Substance use and function questionnaire
  • Admissions to hospital
  • Number of contacts with primary ealth care

Secondary Outcome Measures:
  • Substance use and function questionnaire
  • Admissions to hospital
  • Number of contacts with primary ealth care

Estimated Enrollment: 135
Study Start Date: October 2004
Estimated Study Completion Date: June 2005
Detailed Description:

The aims of the study are in a randomized controlled trial to compare the effects of 2 x 45 minutes Motivational Interviewing and standard treatment with standard treatment alone.All patients acutely admitted to Østmarka Psychiatric Hospital are evaluated for substance use, and all patients with substance use that give their consent to participate are randomized to Motivational Interviewing and standard treatment or standard treatment alone.

Substance use and function will be followed for two years.Admittances to hospital and contacts with primary health care for five years.

  Eligibility

Ages Eligible for Study:   18 Years to 80 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria: adult patients with substance use acutely admitted to psychiatric hospital -

Exclusion Criteria: dementia, serious brain damage,do not speak Norwegian nor English language

-

  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00184223

Locations
Norway
Østmarka Psychiatric Department, St. Olavs Hospital, University Hospital of Trondheim
Trondheim, Norway
Sponsors and Collaborators
Norwegian University of Science and Technology
St. Olavs Hospital
Investigators
Principal Investigator: Gunnar Morken, MD PhD Norwegian University of Science and Technology
  More Information

No publications provided by Norwegian University of Science and Technology

Additional publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
ClinicalTrials.gov Identifier: NCT00184223     History of Changes
Other Study ID Numbers: GB-MI-2004
Study First Received: September 13, 2005
Last Updated: July 24, 2006
Health Authority: Norway: Norwegian Social Science Data Services

Keywords provided by Norwegian University of Science and Technology:
Motivational Interviewing
Substance abuse
Acuteley admitted psychiatric patients

Additional relevant MeSH terms:
Substance-Related Disorders
Chemically-Induced Disorders
Mental Disorders

ClinicalTrials.gov processed this record on September 16, 2014